title: The role of methotrexate in the management of steroid-dependent asthma.
abstract: Severe asthma often requires high-dose corticosteroid therapy. However, steroid therapy is fraught with many side effects. There are conflicting reports in the literature regarding the role of methotrexate in reducing the steroid requirements of these patients. This study examined the role of low-dose methotrexate in the management of steroid-dependent asthma. Eleven subjects with stable steroid-dependent asthma were enrolled in a placebo-controlled double-blind crossover trial. Patients received methotrexate, 15 mg/wk, or placebo each for two 12-week periods. There was significant improvement of pulmonary function and reduction of prednisone requirement in both placebo and methotrexate treatment periods. However, methotrexate was not superior to placebo. Only 3 of 11 patients responded to methotrexate. Although low-dose methotrexate therapy may have a role in a small select group of steroid-dependent asthmatics, it provided no additional benefit overall.
authors.affiliation: Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor.
authors.forename: M J
authors.initials: MJ
authors.lastname: Coffey
authors.forename: G
authors.initials: G
authors.lastname: Sanders
authors.forename: W L
authors.initials: WL
authors.lastname: Eschenbacher
authors.forename: A
authors.initials: A
authors.lastname: Tsien
authors.forename: S
authors.initials: S
authors.lastname: Ramesh
authors.forename: R W
authors.initials: RW
authors.lastname: Weber
authors.forename: G B
authors.initials: GB
authors.lastname: Toews
authors.forename: W J
authors.initials: WJ
authors.lastname: McCune
mesh_terms: D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004311:Double-Blind Method; D005541:Forced Expiratory Volume / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000503:physiopathology; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate / Q000187:drug effects / Q000502:physiology; D010919:Placebos; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D012123:Pulmonary Ventilation / Q000187:drug effects / Q000502:physiology; D013147:Spirometry; D013806:Theophylline / Q000008:administration & dosage / Q000627:therapeutic use; D014797:Vital Capacity / Q000187:drug effects / Q000502:physiology
chemical_list: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D010919:Placebos; D013806:Theophylline; D011241:Prednisone; D008727:Methotrexate